Literature DB >> 25041554

Incidence and mortality of bullous pemphigoid in north-east Poland (Podlaskie Province), 1999-2012: a retrospective bicentric cohort study.

Agnieszka B Serwin1, Ewa Musialkowska, Marta Piascik.   

Abstract

BACKGROUND: Bullous pemphigoid (BP) is the most frequently encountered autoimmune blistering disorder, affecting mainly elderly population. The aim of the study was to assess the incidence of BP in Podlaskie Province (north-east Poland) in 1999-2012, socio-demographic characteristics and mortality of patients with BP.
METHODS: The number of newly diagnosed (in two regional hospitals) cases of BP per million inhabitants of the province in consecutive years was calculated and analysis of age, sex, and residency of patients performed.
RESULTS: A total of 122 cases of BP were diagnosed (in 52 males and 70 females). The average annual incidence was 7.38 ± 3.51 per million inhabitants: 5.70 ± 4.16 and 9.26 ± 4.40 in urban and rural areas, P < 0.05, respectively, and had an increasing trend over the period analyzed. Age of patients with BP was 74.18 ± 12.12. The incidence among men and women over 75 years of age was 86.67 ± 61.39 and 51.49 ± 41.44, P < 0.05, respectively. The 1-year mortality of patients was 32.35 and 18.42% (P < 0.05) in men and women, respectively. Overall mortality was 36.11%.
CONCLUSIONS: The incidence of BP in Podlaskie Province is almost twice as high among residents of rural than urban areas, and in males than females in advanced age. The results suggest that the incidence of BP will be increasing in an aging society, as will its impact on the quality of life of the population.
© 2014 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2014        PMID: 25041554     DOI: 10.1111/ijd.12492

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  8 in total

Review 1.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 3.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

4.  A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry.

Authors:  Janet Lee; Kristina Seiffert-Sinha; Kristopher Attwood; Animesh A Sinha
Journal:  Front Immunol       Date:  2019-09-20       Impact factor: 7.561

5.  Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.

Authors:  Xianxia Chen; Yaqiang Zhang; Zhicheng Luo; Yujuan Wu; Taoxiang Niu; Jiayuan Zheng; Yuanyuan Xie
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.752

6.  Mortality and Comorbidity Profiles of Patients with Bullous Pemphigoid in Korea.

Authors:  Hyeon Woo Jeon; Sook Jung Yun; Seung-Chul Lee; Young Ho Won; Jee-Bum Lee
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444

Review 7.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10

8.  A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up

Authors:  Zekayi Kutlubay; Ayşegül Sevim Keçici; Uğur Çelik; Mehmet Cem Mat
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.